维普中文期刊产品整合服务
104篇 您的检索式:作者名="Maat MP"
    题名 作者 年代 出处 被引量
1Preeclampsia and its interaction with common variants in thrombophilia genes显示文摘De Maat MP Jansen MW Hille ET 2004J Thromb Haemost2004,2,9:1
2C-reactive pro- tein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study 显示文摘Van Der Meer IM De Maat MP Hak AE 2002Stroke2002,33,12:1
3Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease:a review显示文摘van Schie MC van Loon JE de Maat MP 0,,05:1
4The val- ue of C-realive protein in cardiovascular risk predictionthe Rotterdam study显示文摘Van der Meer IM de Maat MP Kiliaan AJ 2003Arch Intern Med2003,163,11:1
5C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree : the rotterdam study 显示文摘van Der Meer IM de Maat MP Hak AE 2002Stroke2002,33,:1
6Genetic variation,C-reactive protein levels,and incidence of diabetes显示文摘Dehghan A Kardys I de Maat MP 2007Diabetes2007,56,3:1
7Variation in the von Willebrand factor gene is associated with von Willebrand factor levels and with the risk for cardiovascular disease 显示文摘van Schie MC de Maat MP Isaacs A 2011Blood2011,117,:1
8Genetic determinants of von WiUebrand factor levels and activity in relation to the risk of cardiovascular disease: a review 显示文摘van Schie MC van Loon JE de Maat MP 2011J Thromb Haemost2011,9,:1
9Reduced ADAMTS13 in children with severe meningoceccal sepsis is associated with severity and outcome显示文摘Bongers TN Emonts M de Maat MP 2010Thromb Haemost2010,103,6:1
10The association between inflammation markers, coronary artery disease and smoking 显示文摘De Maat MP Kluft C 2002Vascul Pharmacol2002,39,3:1
11C-reactive protein as a risk factor versus risk marker显示文摘de Maat MP Trion A 2004Curr Opin Lipidol2004,15,6:1
12Genetic variation,C-reactive protein levels,an incidence of diabetes显示文摘Dehghan A Kardys I De Maat MP 2007Diabetes2007,56,3:1
13C - reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam study显示文摘Van Der Meer IM De Maat MP Hak AE 2002Stroke2002,33,12:1
14A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals显示文摘Brugts JJ Isaacs A de Maat MP 2011J Hypertens2011,29,3:1
15Prog- nostic markers in young patients with premature cor onary heart disease显示文摘Van Loon JE de Maat MP Deckers JW 2012Atherosclerosis2012,224,1:1
16Inflammation, thrombosis and atherosclerosis: results of the Glostrup study显示文摘 Bladbjerg EM Drivsholm T 2003J Thromb Haemost2003,1,5:1
17Determination of the habitual low blood level of C-re- active protein in individuals显示文摘Kluft C de Maat MP 2001Ital Heart J2001,2,3:1
18Genetic variation in thrombin-activatable ~ibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis显示文摘Bruijne EL Darwish Murad S de Maat MP 2007Thromb Haemost2007,97,2:1
19Elevated plasma fibrinogen: cause or consequence of cardiovascular disease显示文摘 de Maat MP Bots ML 1998Arterioscler Thromb Vasc Biol1998,18,:1
20An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease in men显示文摘Agema WR Maat MP Zwinderman AH 2004Clin Sci(Lond)2004,107,3:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费